Westat is committed to continuing the trusted partnership with NIH/NIDA and FDA/CTP on the Population Assessment of Tobacco and Health (PATH) Study to understand tobacco use patterns and impacts on public health.
ROCKVILLE, Md., Feb. 21, 2024 /PRNewswire/ — The National Institutes of Health’s (NIH’s) National Institute on Drug Abuse (NIDA) and the U.S. Food and Drug Administration’s (FDA’s) Center for Tobacco Products (CTP) have announced the award of a third contract to Westat to continue to support the Population Assessment of Tobacco and Health (PATH) Study. Westat has supported the study since its inception in 2011.
Leave a Reply